Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-18

Clinical Trial Update: Liposomal Bupivacaine Single-Injection Interscalene Block vs. Continuous Interscalene Block for Primary Total Shoulder Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 trial comparing single-injection liposomal bupivacaine interscalene block to a continuous interscalene block for pain control after primary total should…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Mayo Clinic | Conditions: Pain, Postoperative, Brachial Plexus Block | Phase 4 | Status: COMPLETED | Results posted: 2023-12-18